DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,971,739 | -5.4% | 977,003 | +4.5% | 0.00% | 0.0% |
Q1 2024 | $11,598,371 | -17.3% | 934,599 | -6.8% | 0.00% | -33.3% |
Q4 2023 | $14,024,247 | -30.2% | 1,003,165 | -26.2% | 0.00% | -25.0% |
Q3 2023 | $20,083,198 | +37.8% | 1,359,729 | +20.5% | 0.00% | +33.3% |
Q2 2023 | $14,573,735 | +31.1% | 1,127,998 | -0.4% | 0.00% | +50.0% |
Q1 2023 | $11,112,856 | -11.0% | 1,132,809 | -3.4% | 0.00% | -33.3% |
Q4 2022 | $12,482,773 | +16.4% | 1,173,193 | +14.2% | 0.00% | 0.0% |
Q3 2022 | $10,724,000 | -14.1% | 1,027,276 | +3.6% | 0.00% | 0.0% |
Q2 2022 | $12,481,000 | +224.5% | 991,336 | +179.4% | 0.00% | +200.0% |
Q1 2022 | $3,846,000 | -26.0% | 354,756 | -4.0% | 0.00% | 0.0% |
Q4 2021 | $5,198,000 | -32.9% | 369,397 | -8.4% | 0.00% | -50.0% |
Q3 2021 | $7,745,000 | +147.0% | 403,151 | +26.7% | 0.00% | +100.0% |
Q2 2021 | $3,135,000 | -21.4% | 318,302 | -21.6% | 0.00% | 0.0% |
Q1 2021 | $3,990,000 | +112.6% | 405,909 | -3.8% | 0.00% | – |
Q4 2020 | $1,877,000 | +3.8% | 421,752 | +0.7% | 0.00% | – |
Q3 2020 | $1,809,000 | -46.4% | 418,758 | +10.1% | 0.00% | -100.0% |
Q2 2020 | $3,375,000 | +175.3% | 380,440 | +9.5% | 0.00% | – |
Q1 2020 | $1,226,000 | -41.7% | 347,350 | -5.5% | 0.00% | -100.0% |
Q4 2019 | $2,103,000 | +100.9% | 367,682 | +25.6% | 0.00% | – |
Q3 2019 | $1,047,000 | -0.9% | 292,713 | +10.6% | 0.00% | – |
Q2 2019 | $1,056,000 | -47.7% | 264,691 | -4.2% | 0.00% | -100.0% |
Q1 2019 | $2,018,000 | -20.0% | 276,222 | +0.1% | 0.00% | 0.0% |
Q4 2018 | $2,524,000 | -26.1% | 275,812 | +0.2% | 0.00% | 0.0% |
Q3 2018 | $3,415,000 | -18.7% | 275,396 | -0.0% | 0.00% | 0.0% |
Q2 2018 | $4,202,000 | -30.5% | 275,495 | -9.5% | 0.00% | -50.0% |
Q1 2018 | $6,042,000 | +6.9% | 304,417 | +0.7% | 0.00% | +100.0% |
Q4 2017 | $5,654,000 | -26.9% | 302,370 | -15.9% | 0.00% | -50.0% |
Q3 2017 | $7,733,000 | +219.4% | 359,650 | +43.4% | 0.00% | +100.0% |
Q2 2017 | $2,421,000 | +129.9% | 250,862 | +41.7% | 0.00% | – |
Q1 2017 | $1,053,000 | +56.5% | 176,996 | +3.9% | 0.00% | – |
Q4 2016 | $673,000 | -61.7% | 170,373 | +1.8% | 0.00% | -100.0% |
Q3 2016 | $1,755,000 | -35.9% | 167,307 | -11.0% | 0.00% | 0.0% |
Q2 2016 | $2,740,000 | -28.8% | 187,933 | -6.1% | 0.00% | 0.0% |
Q1 2016 | $3,849,000 | -22.7% | 200,066 | -3.0% | 0.00% | -50.0% |
Q4 2015 | $4,982,000 | -17.4% | 206,225 | -16.1% | 0.00% | 0.0% |
Q3 2015 | $6,034,000 | +10.6% | 245,924 | +5.5% | 0.00% | 0.0% |
Q2 2015 | $5,458,000 | +25.8% | 233,018 | +20.5% | 0.00% | +100.0% |
Q1 2015 | $4,338,000 | +79.3% | 193,433 | +34.8% | 0.00% | 0.0% |
Q4 2014 | $2,419,000 | – | 143,473 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |